Patent · US Active

Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix

US8906420B2 · kind B2 · utility

18Cited by

43References

21Claims

0Family size

Assignee

Forward Pharma A/S · DK

Inventors

Henrik Nilsson · Copenhagen, DK
Roland Rupp · Bensberg, DE

Key dates

Filing date	Jan 8, 2010
Grant date	Dec 9, 2014
Priority date	—
Expiry date	Jan 8, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical formulation comprising an erosion matrix comprising one or more fumaric acid esters as well as one or more rate-controlling agents, wherein erosion of said erosion matrix permits controlled release of said fumaric acid ester(s).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.